1109289-42-0

Basic information

• Product Name: 4-(3,5-DichlorobenzaMido)-N-(piperidin-4-yl)-1H-pyrazole-3-carboxaMide
• Synonyms: 4-(3,5-DichlorobenzaMido)-N-(piperidin-4-yl)-1H-pyrazole-3-carboxaMide
• CAS NO: 1109289-42-0
• Molecular Formula: C16H17Cl2N5O2
• Molecular Weight: 382.24448
• Mol File: 1109289-42-0.mol
• Article Data: 11

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-(3,5-DichlorobenzaMido)-N-(piperidin-4-yl)-1H-pyrazole-3-carboxaMide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(3,5-DichlorobenzaMido)-N-(piperidin-4-yl)-1H-pyrazole-3-carboxaMide(1109289-42-0)
• EPA Substance Registry System: 4-(3,5-DichlorobenzaMido)-N-(piperidin-4-yl)-1H-pyrazole-3-carboxaMide(1109289-42-0)

Safety Data

• Hazardous Substances Data: 1109289-42-0(Hazardous Substances Data)

Upstream product

• 87120-72-7 1-(tert-butoxycarbonyl)-4-aminopiperidine 
• 844443-80-7 4-[(4-nitro-1H-pyrazole-3-carbonyl)amino]piperidine-1-carboxylic acid tert-butyl ester 
• 123-91-1 1,4-dioxane 
• 844443-90-9 tert-butyl 4-(4-(2,6-dichlorobenzamido)-1H-pyrazole-3-carboxamido)piperidine-1-carboxylate 
• 902135-91-5 AT7519 

Relevant articles and documents

Tartaric acid addition salt of 3,4-disubstituted 1H-pyrazole compound and crystal form thereof

The invention provides one or more pharmaceutical composition of 4-(2,6-dichloro-benzoyl) amino)-1H-pyrazole-3-formate piperidine-4-yl-acyl tartaric acid addition salt, a crystallization form of the tartaric acid addition salt and use of the tartaric acid

PHARMACEUTICAL COMBINATIONS

The invention provides a combination comprising an ancillary compound and a compound having the formula (0): or salts or tautomers or N-oxides or solvates thereof; wherein X is a group R1-A-NR4- or a 5- or 6-membered carbocyclic or h

MEDICAL USE OF CYCLIN DEPENDENT KINASES INHIBITORS

The invention provides the use of a compound for the manufacture of a medicament for the treatment of pain, wherein the compound is a compound of the formula (0) : or a salt or tautomers or N-oxides or solvate thereof; wherein X is a group R1-A